The excuses government leaders give for failing to adequately research ME/CFS can no longer be tolerated. Every individual is at risk for developing this disabling NeuroEndocrineImmune disease. ME/CFS has languished on crumbs of private funding for decades while other illnesses get as much as 22% more research funding from the government.
The recent Norwegian discovery of dramatic improvement resulting from an anti-lymphoma drug shows that the solution is within reach. The problem is a lack of will, and wrong priorities.
The call from ME/CFS patients is the same across the globe:
Notice these funding amounts by disease when compared to the prevalence rate.
NIH Budget for 2012 and Disease Prevalence
NIH Funding: http://report.nih.gov/rcdc/categories/
CDC 2009 Funding Request
CDC Budget Request for 2009 http://www.cdc.gov/fmo/PDFs/FY09budgetreqsummary.pdf